Patient and HCP Preference for a New Epinephrine Nasal Delivery Device
Patient and HCP preference for a new epinephrine nasal delivery device Written by: Erin Pohl Imagine the moment when a child has an allergic reaction and starts gasping for air because their throat is closing. The parent then has to find the life-saving medication and give it quickly and accurately to the child who may or may not be willing. This moment can happen anywhere and at anytime. The standard treatment for anaphylactic shock is epinephrine which is currently delivered via autoinjectors and syringes. To overcome known usability issues with epinephrine injectors like the EpiPen®️, Bryn Pharma, LLC is looking into a new route and device to deliver epinephrine-- the BiDose Epinephrine Nasal Spray. This new nasal spray device provides two intranasal sprays that are absorbed immediately through the mucous membranes in the nose to counteract anaphylaxis. Earlier this year, Core Human Factors teamed up with Bryn Pharma to investigate users’ preferences between the BiDose Epi...